Tumor Specific VEGF-A and VEGFR2/KDR Protein are Co-expressed in Breast Cancer

By Rydén Lisa   Linderholm Barbro   Nielsen Niels Hilmer   Emdin Stefan   Jönsson Per-Ebbe   Landberg Göran  

Breast Cancer Research and Treatment, Vol. 82, Iss. 3, 2003-12 ,pp. : 147-154

Springer Publishing Company

Access to resources Recommend Favorite

Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response

By Rydén Lisa  

Breast Cancer Research and Treatment, Vol. 89, Iss. 2, 2005-01 ,pp. : 135-143

Springer Publishing Company

Access to resources Recommend Favorite

Genetic variations in VEGF and VEGFR2 and glioblastoma outcome

By Sjöström S.  

Journal of Neuro-Oncology, Vol. 104, Iss. 2, 2011-09 ,pp. : 523-527

Springer Publishing Company

Access to resources Recommend Favorite

Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro

By                    

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 1080-1086

Spandidos Publications

Access to resources Recommend Favorite

Anti-angiogenic effect of tanshinone IIA involves inhibition of the VEGF/VEGFR2 pathway in vascular endothelial cells

By  

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 163-170

Spandidos Publications

Access to resources Recommend Favorite